Inclusion of antimicrobial resistance in a pandemic agreement: why it matters and what comes next?
Jesic Beckham, Rishabh Jain, Delaram Haghgozar, Enrique Castro-Sanchez, Jyoti Joshi, Mirfin Mpundu, Rifat Atun, Raheelah Ahmad, Dawn Sievert, Dawn Sievert, Direk Limmathurotsakul, Jyoti Joshi, Kamini Walia, Mirfin Mpundu, Nick Feasey, Rifat Atun, Rogier van Doorn, Sharon Peacock

TL;DR
This paper examines how including antimicrobial resistance in a pandemic agreement can help address a major global health threat.
Contribution
The paper evaluates the implications of including AMR in the pandemic agreement and identifies key challenges and drivers for its implementation.
Findings
Only 2 out of 56 studies were empirical, highlighting a lack of research on the topic.
Challenges like inequity, poor governance, and insufficient funding hinder AMR reduction.
Strengthening governance and ensuring equity are critical for successful implementation.
Abstract
Antimicrobial resistance (AMR), referred to as the “constant pandemic,” exceeds malaria and HIV as a cause of mortality across low- and middle-income countries. As AMR has been included in the recently adopted world's first pandemic agreement, we assessed the implications going forward for addressing AMR and meeting the UN General Assembly AMR targets. A rapid literature review was conducted to synthesize policy perspectives and empirical literature using 3 databases (PubMed, Embase, and CABI—Global Health) for studies published from December 2021 to May 2025. Of the 56 included studies, only 2 were empirical research. Inductive and deductive analyses using the Organization for Economic Co-operation and Development framework with a force-field analysis were used to identify drivers and factors that may impede AMR reduction via the pandemic agreement. Challenges include inequity,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntibiotic Use and Resistance · Zoonotic diseases and public health · Antibiotic Resistance in Bacteria
